Table 1 Baseline characteristics of subjects according to tertiles of GPR level.
GRP tertiles | T1 (≤ 1.372) | T2 (1.375–1.658) | T3 (≥ 1.659) | P-value |
|---|---|---|---|---|
N = 784 | 258 | 263 | 263 | |
Age (years) | 77.10 ± 12.98 | 77.35 ± 12.15 | 78.46 ± 11.81 | 0.518 |
Gender (male), n (%) | 110 (42.64%) | 118 (44.87%) | 113 (42.97%) | 0.857 |
Ischemic stroke subtypes (TOAST) | 0.903 | |||
Large-artery atherosclerosis | 20 (7.75%) | 23 (8.75%) | 28 (10.65%) | |
Cardioembolism | 21 (8.14%) | 27 (10.27%) | 22 (8.37%) | |
Small-vessel occlusion | 11 (4.26%) | 9 (3.42%) | 10 (3.80%) | |
Other determined etiology | 0 (0.00%) | 1 (0.38%) | 1 (0.38%) | |
Undetermined | 206 (79.84%) | 203 (77.19%) | 202 (76.81%) | |
Department | 0.369 | |||
Medical | 257 (99.61%) | 263 (100.00%) | 261 (99.24%) | |
Surgical | 1 (0.39%) | 0 (0.00%) | 2 (0.76%) | |
Serum-sodium (mmol/L) | 139.84 ± 3.37 | 139.51 ± 3.23 | 139.17 ± 4.12 | 0.105 |
Serum-calcium (mmol/L) (1 missing) | 2.34 ± 0.11 | 2.35 ± 0.13 | 2.35 ± 0.13 | 0.428 |
Seum-albumin (mmol/L) (2 missing) | 39.44 ± 3.91 | 39.28 ± 3.67 | 38.92 ± 4.03 | 0.164 |
Serum-phosphate tertiles (mmol/L), n (%) | 0.045 | |||
Tertile1 (≤ 0.97) | 17 (6.59%) | 38 (14.45%) | 30 (11.41%) | |
Tertile2 (0.98–1.12) | 25 (9.69%) | 26 (9.89%) | 37 (14.07%) | |
Tertile3 (≥ 1.13) | 39 (15.12%) | 32 (12.17%) | 29 (11.03%) | |
Not recorded | 177 (68.60%) | 167 (63.50%) | 167 (63.50%) | |
Serum-magnesium tertiles (mmol/L), n (%) | 0.312 | |||
Tertile1 (≤ 0.78) | 19 (7.36%) | 30 (11.41%) | 38 (14.45%) | |
Tertile2 (0.79–0.84) | 30 (11.63%) | 32 (12.17%) | 27 (10.27%) | |
Tertile3 (≥ 0.85) | 37 (14.34%) | 34 (12.93%) | 36 (13.69%) | |
Not recorded | 172 (66.67%) | 167 (63.50%) | 162 (61.60%) | |
Hyperlipemia, n (%) | 13 (5.04%) | 10 (3.80%) | 7 (2.66%) | 0.368 |
Hypertension, n (%) | 61 (23.64%) | 66 (25.10%) | 64 (24.33%) | 0.928 |
AF, n (%) | 60 (23.26%) | 64 (24.33%) | 85 (32.32%) | 0.038 |
Heart failure, n (%) | 7 (2.71%) | 10 (3.80%) | 6 (2.28%) | 0.567 |
Chronic renal failure, n (%) | 10 (3.88%) | 11 (4.18%) | 12 (4.56%) | 0.926 |
Acute renal failure, n (%) | 5 (1.94%) | 6 (2.28%) | 7 (2.66%) | 0.859 |
COPD, n (%) | 3 (1.16%) | 5 (1.90%) | 2 (0.76%) | 0.497 |
CHD, n (%) | 14 (5.43%) | 18 (6.84%) | 10 (3.80%) | 0.301 |
Cancer, n (%) | 0 (0.00%) | 7 (2.66%) | 7 (2.66%) | 0.030 |
Malnutrition, n (%) | 5 (1.94%) | 7 (2.66%) | 6 (2.28%) | 0.859 |
Dehydration, n (%) | 8 (3.10%) | 6 (2.28%) | 15 (5.70%) | 0.095 |
Pneumonia, n (%) | 6 (2.33%) | 12 (4.56%) | 18 (6.84%) | 0.048 |
30-day mortality | 18 (6.98%) | 22 (8.37%) | 36 (13.69%) | 0.024 |
